Skip to main content
Log in

Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level

  • Short Notes
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

A technique was developed, which made it possible to study thein vitro release of3H-acetylcholine (3H-ACh) from human post mortem brain tissue, collected with short post-mortem delay (2,5–22 hours), both from controls and patients with Alzheimer's disease (AD/SDAT). The tritium (3H) release was investigated during potassium stimulation, and AD/SDAT cortical slices were found to release a decreased amount of3H compared to control brain slices. Physostigmine, 10−5 and 10−4 M, has no significant effect on the release of3H from control slices, while physostigmine 10−4 M increased the evoked release from AD/SDAT brain slices over threefold, nearly to the control level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bartus RT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417

    Google Scholar 

  • Beani L, Bianchi C, Siniscalchi A, Sivilotti L, Tanganelli S, Veratti E (1984) Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux. Naunyn Schmiedebergs Arch Pharmacol 328: 119–126

    Google Scholar 

  • Beani L, Bianchi C, Nilsson L, Nordberg A, Romanelli L, Sivilotti L (1985) The effect of nicotine and cytisine on3H-acetylcholine release from cortical slices of guinea-pig brain. Naunyn Schmiedebergs Arch Pharmacol 331: 293–296

    Google Scholar 

  • Bourdois PS, Mitchell JF, Somogyi GT, Szerb JC (1974) The output per stimulus of acetylcholine from cerebral cortical slices in the presence or absence of cholinesterase inhibition. Br J Pharmacol 52: 509–517

    Google Scholar 

  • Briggs CA, Cooper JR (1982) Cholinergic modulation of the release of3H-acetylcholine from synaptosomes of the myenteric plexus. J Neurochem 38: 501–508

    Google Scholar 

  • Caulfield M, Smith C (1985) British pharmacological society symposium: Alzheimer's disease-central cholinergic mechanisms. Lancet ii: 61–63

    Google Scholar 

  • Corkin S (1981) Acetylcholine, aging and Alzheimer's disease. Trend Neuro Sci 12: 287–290

    Google Scholar 

  • Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407–409

    Google Scholar 

  • Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. New Engl J Med 313: 7–11

    Google Scholar 

  • Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252

    Google Scholar 

  • Gulaya K, Watson M, Vickoroy TM (1986) Examination of cholinergic and neuropeptide receptor alterations in Alzheimer's disease (SDAT). In: Fisher A, Hanin I, Lachman C (eds) Alzheimer's and Parkinson's disease: strategies in research and development. Advances in behavioral biology vol 29. Plenum Press, pp 109–116

  • Hardy JA, Adolfsson R, Alafuzoff, Bucht S, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985 a) Transmitter deficits in Alzheimer's disease. Neurochem Int 7: 545–563

    Google Scholar 

  • Hardy JA, Bateman DE, Kidd AM, Edwardson JA, Singh GB, Dodd PR (1984) Amino acid transport by synaptosomes isolated from post mortem human brain. J Neural Transm 60: 57–62

    Google Scholar 

  • Hardy JA, Dodd PR, Okley AE, Perry RH, Edwardson JA, Kidd AM (1983) Metabolically active synaptosomes can be prepared from frozen rat and human brain. J Neurochem 40: 608–614

    Google Scholar 

  • Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A (1985 b) The patients dying after long terminal phase have acidotic brains; Implications for biochemical measurements on autopsy tissue. J Neural Transm 61: 253–264

    Google Scholar 

  • Hollander E, Mohs RC, Davies KL (1986) Cholinergic approaches to the treatment of Alzheimer's disease. Br Med Bull 42: 97–100

    Google Scholar 

  • Johns CA, Haroutunian V, Greenwald BS, Mohs RC, Davies BM, Kanof P, Horvath TB, Davies KL (1985) Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug Develop Res 5: 77–96

    Google Scholar 

  • Mash DC, Flynn DD, Potter LT (1985) Loss of M 2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115–1117

    Google Scholar 

  • McGeer PL (1984) Aging, Alzheimer's disease, and the cholinergic system. Can J Physiol Pharmacol 62: 741–754

    Google Scholar 

  • Mohs RC, Davies BM, Mathé AA, Rosen WG, Johns CA, Greenwald BS, Horvath TB, Davies KL (1985) Intravenous and oral physostigmine in Alzheimer's disease. Interdiscipl Topics Geront 20: 140–152

    Google Scholar 

  • Nordberg A, Larsson C, Perdahl E, Winblad B (1982) Cholinergic activity in hippocampus in chronic alcoholism. Drug and Alcohol Dependence 10: 333–344

    Google Scholar 

  • Nordberg A, Winblad B (1986) Brain Nicotinic and Muscarinic Receptors in Normal Aging and Dementia. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer's and Parkinson's disease: strategies in research and development. Advances in Behavioral Biology vol 29, Plenum Press, pp 95–108

  • Nordberg A, Adem A, Nilsson L, Winblad B (1986 a) Cholinergic deficits in CNS and peripheral non-neuronal tissue in Alzheimer dementia. In: Dowdell M, Hawthorne J (eds) Cellular and molecular basis of cholinergic function. Ellis-Horward, Chichester (in press)

    Google Scholar 

  • Nordberg A, Alafuzoff I, Winblad B (1986 a) Muscarinic receptor subtypes in hippocampus in dementia of AD/SDAT and AD/MID type. Neurosci Letters (in press)

  • Nordberg A, Winblad B (1986) Reduced number of3H-nicotine and3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Letters (in press)

  • Nordström Ö, Bartfai T (1980) Muscarinic autoreceptor regulates acetylcholine release in the rat hippocampus:in vitro evidence. Acta Physiol 108: 347–353

    Google Scholar 

  • Nordström Ö, Westlind A, Undén A, Meyerson B, Sachs C, Bartfai T (1982) Pre- and postsynaptic muscarinic receptors in surgical samples from human cerebral cortex. Brain res 234: 287–297

    Google Scholar 

  • Perry EK (1986) The cholinergic hypothesis—ten years on. Br Med Bull 42: 63–69

    Google Scholar 

  • Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res 289: 169–175

    Google Scholar 

  • Sims NR, Smith CCT, Davison AN, Bowen DM, Flack RHA, Snowden JS (1980) Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet i: 333–336

    Google Scholar 

  • Stadie WC, Riggs BC (1944) Microtome for the preparation of tissue slices for metabolic studies of surviving tissuein vitro. J Biol Chem 154: 687–690

    Google Scholar 

  • Szerb JC (1975) Endogenous acetylcholine release and labelled acetylcholine formation from3H Choline in the myenteric plexus of the guinea-pig ileum. Can J Physiol Pharmacol 53: 566–574

    Google Scholar 

  • Szerb JC (1976) Storage and release of labelled acetylcholine in the myenteric plexus of the guinea-pig ileum. Can J Physiol Pharmacol 54: 12–22

    Google Scholar 

  • Wikberg J (1977) Release of3H-acetylcholine from isolated guinea-pig ileum. A radiochemical method for studying the release of the cholinergic neurotransmitter in the intestine. Acta Physiol Scand 101: 302–317

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, L., Nordberg, A., Hardy, J. et al. Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level. J. Neural Transmission 67, 275–285 (1986). https://doi.org/10.1007/BF01243353

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01243353

Key words

Navigation